Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Viking Therapeutics (NASDAQ: VKTX) soared to center stage earlier this year as a potentially promising player in one of today ...
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the ...
Pharmaceutical executives and public health experts have warned that Robert F Kennedy jnr’s influence over Donald Trump could ...
That may leave some Americans to question whether they'll find their local stores, banks, post offices, DMV and other services open on November 5. At the same time, some schools are closed on Election ...
CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback